IU Cancer Center receives new and renewed ACS funding for research, education programs

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The Indiana University Melvin and Bren Simon Comprehensive Cancer Center received new and renewed funding from the American Cancer Society to support research and education programs.

IU cancer researchers are currently receiving more than $6 million in multi-year ACS funding across the Indianapolis and Bloomington campuses. 

New this year, the cancer center received a $660,000 grant as one of eight inaugural sites for the American Cancer Society Post-Baccalaureate Diversity in Cancer Research Education Program. The two-year cancer research experience is designed for students of underrepresented background or disadvantaged populations who have recently been awarded their bachelor’s degree and intend to pursue clinical or research careers in cancer.

The post-baccalaureate program prepares participants for competitive MD and PhD programs through hands-on research experiences and includes a $37,565 yearly stipend, a housing stipend, and health insurance during the two-year program. Applications are now being accepted. More information can be found here.

“The IU Simon Comprehensive Cancer Center is fully committed to increasing the diversity of our students and faculty. This will result in more diverse cancer researchers and clinicians to drive future cancer treatments and discoveries,” Mark Kelley, the Betty and Earl Herr Professor of Pediatric Oncology Research at IU School of Medicine and the associate director of basic science research at the cancer center, said in a statement. Kelley serves as the lead cancer center faculty directing the grant.

The ACS also has renewed the cancer center’s ACS Institutional Research Grant to provide pilot project funding to assist early-career cancer investigators, giving them the opportunity to establish their research program and explore innovative ideas. The IRG has been continuously funded by the ACS since 1986 and will provide $360,000 over the next three years.

Now in its second year at the cancer center, the ACS also provides funding for an education program designed to build the pipeline for diversity in cancer research.

The Diversity in Cancer Research internship program aims to increase the number of undergraduate students from underrepresented populations pursuing clinical and research careers in cancer. It is supported via a supplement to the ACS IRG, and directed at the cancer center by Tim Corson and Shannon Hawkins The IU Simon Comprehensive Cancer Center was one of only 12 universities to implement this American Cancer Society internship program last year, which is funded through 2024.

Additionally, six investigators are funded with $4.7 million in multi-year Research Scholar Grants, which support independent, self-directed researchers and clinician scientists. These grants are funding research in ovarian and breast cancers, DNA replication errors in cancer, among other topics.

Current RSG recipients are Lata Balakrishnan, Anirban K. Mitra, Sumegha Mitra, Hengyao Niu, Jenifer Prosperi, and Chi Zhang.

Table of Contents

YOU MAY BE INTERESTED IN

Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center and the IU School of Medicine have discovered that Black patients with breast cancer who are treated with docetaxel experience less peripheral neuropathy. Their findings represent an important shift in knowledge about a patient population who’ve historically been underrepresented in breast cancer research.

The American Cancer Society and the American Society of Clinical Oncology have combined their cancer information resources, which will be available at no cost to the public on cancer.org. The collaboration, which combines the two organizations’ sites—ACS’s cancer.org and ASCO’s cancer.net—was announced at the 2024 ASCO Annual Meeting in Chicago May 1. Cancer.org is now...

Login